ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/01/30 | 4,620 | 4,720 | 4,565 | 4,625 | +75 | +1.6% | 2,281,300 |
| 2018/01/29 | 4,580 | 4,635 | 4,545 | 4,550 | -15 | -0.3% | 883,900 |
| 2018/01/26 | 4,465 | 4,580 | 4,450 | 4,565 | +90 | +2% | 817,600 |
| 2018/01/25 | 4,515 | 4,560 | 4,435 | 4,475 | -80 | -1.8% | 1,114,300 |
| 2018/01/24 | 4,570 | 4,605 | 4,510 | 4,555 | -45 | -1% | 1,142,100 |
| 2018/01/23 | 4,535 | 4,645 | 4,510 | 4,600 | +95 | +2.1% | 1,235,700 |
| 2018/01/22 | 4,440 | 4,540 | 4,405 | 4,505 | +45 | +1% | 993,300 |
| 2018/01/19 | 4,450 | 4,525 | 4,410 | 4,460 | +50 | +1.1% | 1,242,800 |
| 2018/01/18 | 4,350 | 4,470 | 4,290 | 4,410 | +75 | +1.7% | 1,488,300 |
| 2018/01/17 | 4,160 | 4,350 | 4,160 | 4,335 | +115 | +2.7% | 1,103,500 |
| 2018/01/16 | 4,290 | 4,295 | 4,190 | 4,220 | -85 | -2% | 1,364,600 |
| 2018/01/15 | 4,440 | 4,440 | 4,270 | 4,305 | -70 | -1.6% | 1,502,000 |
| 2018/01/12 | 4,265 | 4,400 | 4,240 | 4,375 | +110 | +2.6% | 1,400,900 |
| 2018/01/11 | 4,250 | 4,320 | 4,185 | 4,265 | +15 | +0.4% | 1,269,200 |
| 2018/01/10 | 4,095 | 4,265 | 4,095 | 4,250 | +180 | +4.4% | 1,961,600 |
| 2018/01/09 | 3,950 | 4,115 | 3,940 | 4,070 | +175 | +4.5% | 1,986,900 |
| 2018/01/05 | 3,920 | 3,940 | 3,880 | 3,895 | -30 | -0.8% | 695,600 |
| 2018/01/04 | 3,930 | 3,960 | 3,860 | 3,925 | +65 | +1.7% | 908,900 |
| 2017/12/29 | 3,900 | 3,945 | 3,855 | 3,860 | -40 | -1% | 552,400 |
| 2017/12/28 | 3,980 | 4,010 | 3,890 | 3,900 | -60 | -1.5% | 797,900 |
| 2017/12/27 | 3,885 | 3,970 | 3,875 | 3,960 | +80 | +2.1% | 875,800 |
| 2017/12/26 | 3,855 | 3,930 | 3,835 | 3,880 | +25 | +0.6% | 537,100 |
| 2017/12/25 | 3,850 | 3,890 | 3,835 | 3,855 | -5 | -0.1% | 326,700 |
| 2017/12/22 | 3,865 | 3,865 | 3,815 | 3,860 | -10 | -0.3% | 433,300 |
| 2017/12/21 | 3,840 | 3,890 | 3,835 | 3,870 | +50 | +1.3% | 552,200 |
| 2017/12/20 | 3,945 | 3,950 | 3,815 | 3,820 | -125 | -3.2% | 1,219,500 |
| 2017/12/19 | 3,900 | 4,040 | 3,845 | 3,945 | +80 | +2.1% | 1,942,800 |
| 2017/12/18 | 3,845 | 3,880 | 3,820 | 3,865 | +45 | +1.2% | 1,232,000 |
| 2017/12/15 | 3,760 | 3,830 | 3,745 | 3,820 | +65 | +1.7% | 1,543,100 |
| 2017/12/14 | 3,700 | 3,775 | 3,690 | 3,755 | +75 | +2% | 972,000 |
| 2017/12/13 | 3,670 | 3,690 | 3,645 | 3,680 | +25 | +0.7% | 601,600 |
| 2017/12/12 | 3,635 | 3,680 | 3,620 | 3,655 | +20 | +0.6% | 580,000 |
| 2017/12/11 | 3,665 | 3,680 | 3,590 | 3,635 | +5 | +0.1% | 404,300 |
| 2017/12/08 | 3,570 | 3,650 | 3,570 | 3,630 | +15 | +0.4% | 639,100 |
| 2017/12/07 | 3,615 | 3,645 | 3,595 | 3,615 | +20 | +0.6% | 560,900 |
| 2017/12/06 | 3,600 | 3,665 | 3,575 | 3,595 | +15 | +0.4% | 724,200 |
| 2017/12/05 | 3,640 | 3,640 | 3,560 | 3,580 | -85 | -2.3% | 959,500 |
| 2017/12/04 | 3,735 | 3,830 | 3,655 | 3,665 | -85 | -2.3% | 1,377,600 |
| 2017/12/01 | 3,740 | 3,775 | 3,700 | 3,750 | +5 | +0.1% | 768,300 |
| 2017/11/30 | 3,740 | 3,775 | 3,690 | 3,745 | -15 | -0.4% | 1,001,800 |
| 2017/11/29 | 3,655 | 3,785 | 3,630 | 3,760 | +135 | +3.7% | 1,654,000 |
| 2017/11/28 | 3,645 | 3,655 | 3,590 | 3,625 | -50 | -1.4% | 621,000 |
| 2017/11/27 | 3,605 | 3,705 | 3,580 | 3,675 | +70 | +1.9% | 981,200 |
| 2017/11/24 | 3,530 | 3,640 | 3,515 | 3,605 | +75 | +2.1% | 834,700 |
| 2017/11/22 | 3,715 | 3,715 | 3,525 | 3,530 | -150 | -4.1% | 1,516,000 |
| 2017/11/21 | 3,640 | 3,735 | 3,615 | 3,680 | +45 | +1.2% | 1,663,300 |
| 2017/11/20 | 3,495 | 3,680 | 3,465 | 3,635 | +115 | +3.3% | 2,753,300 |
| 2017/11/17 | 3,500 | 3,575 | 3,430 | 3,520 | +280 | +8.6% | 3,524,100 |
| 2017/11/16 | 3,165 | 3,265 | 3,130 | 3,240 | +55 | +1.7% | 802,400 |
| 2017/11/15 | 3,230 | 3,335 | 3,165 | 3,185 | -30 | -0.9% | 1,429,800 |
1801～
1850
件表示中 / 2936件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 166,000円 | +5.0% | +1.5% | 0.00% | 14.20倍 | 3.78倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 356,700円 | +8.0% | -15.3% | 3.48% | 10.01倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サンバイオ | 322,000円 | - | - | 0.00% | - | 149.14倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| サワイＧＨＤ | 181,600円 | +5.9% | +684.6% | 3.03% | 12.05倍 | 1.21倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 420,000円 | +3.6% | +6.1% | 2.86% | 14.15倍 | 0.83倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
